via abileneadvancedeyecare.com
Eye experts are leading a landmark trial in the UK of a new drug that could slow the progression of an untreatable form of blindness.
Patients who have suffered some visual loss due to geographic atrophy (GA) – an advanced form of dry age-related macular degeneration (AMD) – are receiving injections of lampalizumab.
It is believed the treatment, now in its final clinical trial phase, could reduce the area of damage in most sufferers by around 20%.
Some with a particular genetic feature could see the damage reduced by 44%, according to experts at Southampton General Hospital who are leading the UK trials.
The condition, which occurs when cells in the part of the eye responsible for vision become damaged by the build-up of waste deposits called drusen, causes progressive and permanent vision loss.
Despite accounting for 90% of all cases of AMD – the leading cause of blindness in the UK affecting around 500,000 people over the age of 50 – there are no approved treatments for either the early, intermediate or advanced forms of dry AMD.
Professor Andrew Lotery, a consultant ophthalmologist at Southampton General Hospital and the study’s chief investigator in the UK, said the study was a “major milestone” for patients and clinicians.
He said: “Lampalizumab has already been shown to reduce damage caused by GA by 20% in most cases and, for some patients with a specific genetic biomarker, by up to 44% in early-stage trials.
Read more: Blindness breakthrough as new jab could save sight of hundreds of thousands of Britons
The Latest on: Age-related macular degeneration
[google_news title=”” keyword=”Age-related macular degeneration” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Age-related macular degeneration
- Top Countries Data - Ophthalmology for Age-related Macular Degeneration Diseases Market Research Report [2023-2030]on March 28, 2023 at 8:14 pm
Our Most Recent Research Report Indicates that Ophthalmology for Age-related Macular Degeneration Diseases Market is Set to Undergo Significant Changes in 2023 Compared to the Previous Year. [93 Pages ...
- Age-Related Macular Degenerationon March 27, 2023 at 5:00 pm
Age-related macular degeneration (ARMD) is the most common cause of severe vision loss in elderly persons in developed countries and accounts for one-third of cases of untreatable vision loss.
- 2023-2028 Age Related Macular Degeneration Drug Market Growth and Size Analysis by Industry Experts | Latest Research Reporton March 27, 2023 at 5:08 am
The “Age Related Macular Degeneration Drug Market” [100 Pages] offers comprehensive analysis of both historical and ...
- UNITY Biotechnology Announces Results from Phase 2 ENVISION Study of UBX1325 in Patients with Wet Age-Related Macular Degenerationon March 27, 2023 at 5:01 am
UBX1325 monotherapy did not achieve non-inferiority through 24 weeks due, in part, to an unexpected 3.5 letter gain in the anti-VEGF control arm UBX1325 maintained visual acuity in patients with ongoi ...
- Wet Age-Related Macular Degeneration - Pipeline Insight, 2023: Comprehensive Analysis on 80+ Upcoming Drugs - ResearchAndMarkets.comon March 22, 2023 at 2:51 am
The "Wet Age-Related Macular Degeneration - Pipeline Insight, 2023" clinical trials has been added to ResearchAndMarkets.com's offering. This report provides comprehensive insights about 75+ companies ...
- UTSW expert advises screening by 55 for people with family history of age-related macular degenerationon March 21, 2023 at 7:42 pm
Patients with a family history of age-related macular degeneration (AMD), the leading cause of permanent vision loss in those older than 60, should visit an ophthalmologist by age 55 to be screened ...
- Can Machine Learning Detect Age-Related Macular Degeneration?on March 16, 2023 at 5:00 pm
A research team from National Cheng Kung University (NCKU), led by Chih-Chung Hsu, an assistant professor at the Institute of Data Science, NCKU, has demonstrated that machine learning can assist in ...
- How to keep your eyes safe from age-related macular degenerationon March 15, 2023 at 2:29 pm
It’s been said the “eyes are the gateway to the soul.” There is no denying they are an important part of your health, and that they change over time.
- What Is Macular Degeneration?on March 15, 2023 at 10:13 am
Particularly after age 50, many people have concerns about developing the potentially vision-damaging condition known as age-related macular degeneration (AMD). AMD affects the central part of the ...
- Commonly used self-test for age-related macular degeneration found to be inaccurateon February 27, 2023 at 6:50 am
Age-related macular degeneration (AMD) is one the most prevalent eye diseases. In the late stage of the disease, newly formed vessels in the retina alter its structure, which leads to blurry and ...
via Bing News
